Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Pulmonology · Interstitial Lung Disease Due to Surfactant Protein C Deficiency

Monitoring and Outlook: Planning for the Long Term

At a Glance

SP-C deficiency can follow very different paths, so monitoring is personalized and often lifelong. Regular checks of oxygen, growth, lung function, and heart health can detect changes early, while a written action plan helps families respond to warning signs.

Living with surfactant protein C (SP-C) deficiency means entering a long-term relationship with a medical team. Because the disease is “heterogeneous”—meaning it behaves differently in every person—there is no one-size-fits-all schedule for follow-up [1][2]. Instead, monitoring is a custom-built safety net designed to catch changes in lung health before they become crises [3].

The Routine Monitoring Plan

Your care team will use a combination of physical exams, technology, and your own observations to track the disease. While symptom tracking, pulse-ox logs, and weight trends are useful supplements, they do not replace clinical assessment [3][4].

Clinical Assessment and Growth

In children, growth is one of the most sensitive indicators of lung health. If a child’s lungs are working too hard, they may stop gaining weight or even lose weight (poor weight gain) [5].

  • Frequency: This may be every few months for infants or those with active symptoms, or less often for stable older children and adults, as the specialist team sets the schedule [3].
  • Oxygen Saturation: Periodic checks of oxygen levels at rest, during sleep, and during activity (like walking or playing) help determine if oxygen flow needs to be adjusted [6][5].

Pulmonary Function Tests (PFTs)

These tests measure how well the lungs move air and transfer oxygen into the blood.

  • Infant PFTs (iPFT): Specialized centers can perform these on babies under age 2 or 3, but this requires sedation with its own risks and is not universally available [4][7].
  • Spirometry: Once a child is about 5 or 6 years old, they can usually perform standard “blow tests” to measure lung capacity [7].
  • Diffusion Capacity (DLCO): This measures how easily oxygen moves from the air sacs into the bloodstream [8][9].

Imaging and Heart Health

  • High-Resolution CT (HRCT): Scans are usually not repeated on a fixed schedule. This limits radiation exposure while providing a “map” of lung scarring or inflammation when needed [10][11].
  • Echocardiograms: These ultrasounds of the heart screen for pulmonary hypertension (PH), which is high blood pressure in the lung’s arteries. PH is a serious but treatable complication that can develop if lung disease is advanced [12][13].

Recognizing “Red Flags”

While most changes in SP-C deficiency happen slowly, sudden flare-ups of lung inflammation can occur [14]. Everyone should have a one-page written action plan outlining baseline oxygen needs, prescribed targets, and emergency contacts. Note: Home pulse oximeters can be inaccurate due to motion or cold extremities; repeat unexpected readings, and seek emergency help for severe symptoms regardless of the number.

Seek Emergency Care (Call 911/ER) If: Contact Your Pulmonologist If:
Cyanosis: Bluish tint to the lips, tongue, or fingernails [15]. Increased Oxygen Need: You find yourself turning up the oxygen flow more often than usual [5].
Severe Distress: In adults/older children: unable to speak in full sentences. In infants: pauses in breathing, grunting, poor feeding, or marked skin retractions [15]. New or Worsening Cough: A dry cough that lingers for more than a few days [16].
Sudden Oxygen Drop: Pulse oximeter readings significantly lower than your “baseline” threshold [17]. Poor Weight Gain: Your child is struggling to gain weight or seems disinterested in eating [5].
Altered Mental State: Unusual sleepiness, confusion, or extreme irritability [17]. Reduced Activity: Finding that usual activities (like climbing stairs or playing) now cause fatigue [18].

Long-Term Outlook and the “Relapse” Risk

The prognosis for SP-C deficiency is a “spectrum” [1].

  • Variability: Some patients have severe disease in infancy that stabilizes and improves as they grow [1]. Others may have very mild symptoms for years, followed by a gradual decline in their 20s or 30s [8].
  • The Adult Transition: It is known that some people who seemed stable in childhood experience a possible later worsening or manifestation of symptoms in early adulthood [3]. For this reason, lifelong monitoring—even if it’s just once a year—is recommended to catch any silent changes in lung function [3][8].

The Psychological Toll

Managing a rare, chronic condition is taxing. The “watchful waiting” between scans and the uncertainty of the disease’s path can lead to anxiety for both parents and patients [3]. Connecting with organizations like the chILD Foundation, pulmonary-fibrosis resources, or rare disease registries can provide emotional support and keep you updated on new research [5]. Your mental health is just as important as your lung health; don’t hesitate to ask your care team for resources to help manage the emotional impact of this diagnosis.

Common questions in this guide

How often should people with SP-C deficiency be monitored?
There is no single follow-up schedule for SP-C deficiency. Infants or people with active symptoms may be seen every few months, while stable older children and adults may be seen less often. Lifelong follow-up, sometimes annually, can help detect changes that appear later.
What tests are used to follow SP-C deficiency over time?
Clinicians may check oxygen levels at rest, during sleep, and during activity; track growth and weight; perform lung function tests; and use scans when needed. A heart ultrasound can also screen for pulmonary hypertension, which is high blood pressure in the arteries of the lungs.
When should I take someone with SP-C deficiency to the emergency room?
Get emergency help for blue lips, tongue, or fingernails; severe breathing distress; a sudden oxygen drop; or unusual sleepiness, confusion, or extreme irritability. In infants, pauses in breathing, grunting, poor feeding, or marked skin pulling-in are urgent signs. A home oximeter can be inaccurate, so severe symptoms need emergency care even if the number is not very low.
Does SP-C deficiency always get worse?
No. The course is different for each person: severe disease in infancy may stabilize or improve, while mild symptoms can remain quiet for years and then worsen in early adulthood. Because later changes are possible, continued monitoring is important even when breathing seems stable.
How often should CT scans be repeated for SP-C deficiency?
CT scans are not usually repeated on a fixed schedule. The lung specialist weighs symptoms, examination findings, and the need for information against radiation exposure, and may consider lower-dose imaging when appropriate.
How is pulmonary hypertension checked in people with SP-C deficiency?
A heart ultrasound, called an echocardiogram, can screen for pulmonary hypertension, which is high blood pressure in the arteries of the lungs. The pulmonology team can recommend how often screening is needed based on the person’s lung disease and clinical changes.
Can babies with SP-C deficiency have lung function tests?
Some specialized centers can perform infant pulmonary function tests in babies under about 2 or 3 years old, but the testing may require sedation and is not available everywhere. Once children are around 5 or 6, many can perform spirometry, a simple blow test.

Get notified when new evidence is published on Interstitial lung disease due to SP-C deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    Genotype alone does not predict the clinical course of SFTPC deficiency in paediatric patients.

    Kröner C, Reu S, Teusch V, et al.

    The European respiratory journal 2015; (46(1)):197-206 doi:10.1183/09031936.00129414.

    PMID: 25657025
  2. 2

    Surfactant Protein C-associated interstitial lung disease; three different phenotypes of the same SFTPC mutation.

    Salerno T, Peca D, Menchini L, et al.

    Italian journal of pediatrics 2016; (42()):23 doi:10.1186/s13052-016-0235-x.

    PMID: 26925580
  3. 3

    ERS statement on transition of care in childhood interstitial lung diseases.

    Pohunek P, Manali E, Vijverberg S, et al.

    The European respiratory journal 2024; (64(2)) doi:10.1183/13993003.02160-2023.

    PMID: 38843911
  4. 4

    Infant pulmonary function testing in chronic pneumonitis of infancy due to surfactant protein C mutation.

    Hevroni A, Goldman A, Springer C

    Pediatric pulmonology 2015; (50(6)):E17-23 doi:10.1002/ppul.23166.

    PMID: 25755194
  5. 5

    Clinical and genetic spectrum of interstitial lung disease in Chinese children associated with surfactant protein C mutations.

    Hong D, Dai D, Liu J, et al.

    Italian journal of pediatrics 2019; (45(1)):117 doi:10.1186/s13052-019-0710-2.

    PMID: 31462320
  6. 6

    Oxygen for interstitial lung diseases.

    Khor YH, Smith DJF, Johannson KA, Renzoni E

    Current opinion in pulmonary medicine 2020; (26(5)):464-469 doi:10.1097/MCP.0000000000000691.

    PMID: 32657832
  7. 7

    Lung Function Tests in Infants and Children.

    Jat KR, Agarwal S

    Indian journal of pediatrics 2023; (90(8)):790-797 doi:10.1007/s12098-023-04588-8.

    PMID: 37261706
  8. 8

    Similarities and differences of interstitial lung disease associated with pathogenic variants in SFTPC and ABCA3 in adults.

    Diesler R, Legendre M, Si-Mohamed S, et al.

    Respirology (Carlton, Vic.) 2024; (29(4)):312-323 doi:10.1111/resp.14667.

    PMID: 38345107
  9. 9

    Acute exacerbation in interstitial lung disease.

    Alhamad EH, Cal JG, Alrajhi NN, AlBoukai AA

    Annals of thoracic medicine 2021; (16(2)):178-187 doi:10.4103/atm.atm_14_21.

    PMID: 34012485
  10. 10

    2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.

    Johnson SR, Bernstein EJ, Bolster MB, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2024; (76(8)):1201-1213 doi:10.1002/art.42860.

    PMID: 38973714
  11. 11

    Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography.

    Khanna D, Distler O, Cottin V, et al.

    Journal of scleroderma and related disorders 2022; (7(3)):168-178 doi:10.1177/23971983211064463.

    PMID: 36211204
  12. 12

    Congenital Surfactant C Deficiency with Pulmonary Hypertension-A Case Report.

    Chua WC, Chen IC, Liu YC, et al.

    Children (Basel, Switzerland) 2022; (9(10)) doi:10.3390/children9101435.

    PMID: 36291368
  13. 13

    Pulmonary hypertension in childhood interstitial lung disease: A systematic review of the literature.

    Bromley S, Vizcaya D

    Pediatric pulmonology 2017; (52(5)):689-698 doi:10.1002/ppul.23632.

    PMID: 27774750
  14. 14

    Acute Exacerbation of Interstitial Lung Disease: Early Diagnosis and Treatment.

    León-Román F, Martínez-Besteiro E, Iturbe D, et al.

    Medicina (Kaunas, Lithuania) 2025; (61(12)) doi:10.3390/medicina61122097.

    PMID: 41470099
  15. 15

    Approach to the patient with Childhood Interstitial and Diffuse Lung Disease.

    Fiorino EK, Fishman MP

    Pediatric pulmonology 2024; (59(9)):2267-2275 doi:10.1002/ppul.27162.

    PMID: 39056528
  16. 16

    [Familial interstitial lung disease associated with surfactant protein C gene mutation in adults: report of two cases and literature review].

    Wu TT, Yu YM, Tang P, et al.

    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2022; (45(1)):53-58 doi:10.3760/cma.j.cn112147-20210428-00295.

    PMID: 35000306
  17. 17

    Prognostic significance of the ROX index in patients with acute exacerbation of interstitial lung disease treated with high-flow nasal cannula oxygen therapy: a retrospective cohort study.

    Katayama I, Makino H, Sahara S, et al.

    BMC pulmonary medicine 2026; (26(1)).

    PMID: 42056977
  18. 18

    Cardiopulmonary Exercise Testing in Patients With Interstitial Lung Disease.

    Molgat-Seon Y, Schaeffer MR, Ryerson CJ, Guenette JA

    Frontiers in physiology 2020; (11()):832 doi:10.3389/fphys.2020.00832.

    PMID: 32754054

This page is for informational purposes only and does not constitute medical advice. It explains monitoring and warning signs for SP-C deficiency-related interstitial lung disease; follow your pulmonologist’s individualized plan and seek emergency care for severe symptoms.

Guide contents Interstitial lung disease due to SP-C deficiency
Research & Literature
04 Treatment and Daily Management